These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3044254)
1. Modern approaches to vaccine development with special reference to the needs of developing countries. Ada GL Ann Acad Med Singap; 1988 Apr; 17(2):171-6. PubMed ID: 3044254 [TBL] [Abstract][Full Text] [Related]
2. Prospects for the eradication of infectious diseases. Stuart-Harris C Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445 [TBL] [Abstract][Full Text] [Related]
3. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants]. Koprowski H Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429 [TBL] [Abstract][Full Text] [Related]
4. The Children's Vaccine Initiative and vaccine supply: the role of the public sector. van Noort RB Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410 [TBL] [Abstract][Full Text] [Related]
5. Vaccine requirements and priorities for developing countries. Thongcharoen P J Med Assoc Thai; 1986 Sep; 69(9):505-10. PubMed ID: 3794567 [TBL] [Abstract][Full Text] [Related]
6. [Developments in vaccines for prophylactic use (author's transl)]. Hennessen W Zentralbl Bakteriol Orig B; 1976; 163(1-4):55-62. PubMed ID: 1015046 [TBL] [Abstract][Full Text] [Related]
7. Human vaccine research and development: an overview. Kieny MP; Girard MP Vaccine; 2005 Dec; 23(50):5705-7. PubMed ID: 16182415 [TBL] [Abstract][Full Text] [Related]
8. Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses. Sabin AB Eur J Epidemiol; 1991 Mar; 7(2):95-120. PubMed ID: 1646116 [TBL] [Abstract][Full Text] [Related]
9. Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices. Jadhav S; Gautam M; Gairola S Clin Microbiol Infect; 2014 May; 20 Suppl 5():37-44. PubMed ID: 24476201 [TBL] [Abstract][Full Text] [Related]
10. Lessons from measles vaccination in developing countries. Hall AJ; Cutts FT BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878 [TBL] [Abstract][Full Text] [Related]
11. Obstacles to developing vaccines for the Third World. Robbins A; Freeman P Sci Am; 1988 Nov; 259(5):126-33. PubMed ID: 3212439 [TBL] [Abstract][Full Text] [Related]
12. Idiotypic vaccinations: consideration towards a practical application. Eichmann K; Emmrich F; Kaufmann SH Crit Rev Immunol; 1987; 7(3):193-227. PubMed ID: 3113826 [TBL] [Abstract][Full Text] [Related]
13. Vaccines for the Third World. Bloom BR Nature; 1989 Nov; 342(6246):115-20. PubMed ID: 2812009 [No Abstract] [Full Text] [Related]
14. [Eradication of infectious diseases by vaccination]. Saliou P Med Trop (Mars); 2007 Aug; 67(4):321-7. PubMed ID: 17926788 [TBL] [Abstract][Full Text] [Related]
15. [New technologies for vaccine development]. Leclerc C Med Sci (Paris); 2007 Apr; 23(4):386-90. PubMed ID: 17433228 [TBL] [Abstract][Full Text] [Related]
16. The desired field-performance characteristics of new improved vaccines for the developing world. de Quadros CA; Carrasco P; Olivé JM Int J Technol Assess Health Care; 1994; 10(1):65-70. PubMed ID: 8157462 [TBL] [Abstract][Full Text] [Related]
17. Anti-Infectious Human Vaccination in Historical Perspective. D'Amelio E; Salemi S; D'Amelio R Int Rev Immunol; 2016 May; 35(3):260-90. PubMed ID: 26606466 [TBL] [Abstract][Full Text] [Related]
18. Vaccines for viral diseases with dermatologic manifestations. Brentjens MH; Yeung-Yue KA; Lee PC; Tyring SK Dermatol Clin; 2003 Apr; 21(2):349-69. PubMed ID: 12757257 [TBL] [Abstract][Full Text] [Related]